Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 20mg | $175.00$117.00 | $5.85/mg | In stock | Jul 8 |
| vial | 50mg | $440.00$268.00 | $5.36/mg | In stock | Jul 8 |
| vial | 100mg | $880.00$498.00 | $4.98/mg | In stock | Jul 8 |
| vial | 200mg | $1760.00$888.00 | $4.44/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| CJ202606 | — | 99.7% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Unverified | View |
| CJ20250724 | — | 99.6% | TrustPointe Analytics | Endotoxin, Heavy metals |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. CJC-1295 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Peptide Partners sell CJC-1295?
Yes — Peptide Partners currently lists CJC-1295 in 4 variants starting at $888.00 ($4.44/mg).
Is Peptide Partners's CJC-1295 third-party tested?
Yes — Disclosed Labs has indexed 2 Certificates of Analysis for Peptide Partners's CJC-1295, with the most recent showing 99.7% purity. Peptide Partners holds an overall trust grade of A (91/100) across all 106 COAs on file.
What is Peptide Partners's trust grade for CJC-1295?
Peptide Partners has an overall Disclosed Labs trust grade of A (91/100), computed from 106 COAs across all peptides. The most recent CJC-1295 COA was issued by Kovera Labs.
Where is the cheapest CJC-1295?
As of the latest data, Peptide Supply Co. offers CJC-1295 at $3.80/mg — compare with Peptide Partners's listing at $4.44/mg. See the full CJC-1295 price comparison.
Is CJC-1295 legal to buy?
CJC-1295 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Confirmed |
| View |